Welcure Drugs & Pharmaceuticals informs about appointment of CFO

01 Sep 2022 Evaluate

In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’), Welcure Drugs & Pharmaceuticals has informed that on the recommendation of Nomination & Remuneration Committee, the Board of Directors of the Company in their meeting held on 01st September, 2022 has appointed Vishal Mehra as Chief Financial officer (CFO) of the Company with effect from 01.09.2022 In compliance with SEBI order dated June 14, 2018 to Stock Exchange and further SEBI Circular No. LIST/COMP/14/2018-19 dated June 20, 2018: the company has confirmed that Vishal Mehra has not been debarred from holding the office of the Chief Financial Officer by virtue of any SEBI order or any other authority.

The above information is a part of company’s filings submitted to BSE.

Welcure Drugs&Pharma Share Price

12.92 -0.68 (-5.00%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Redington 202.20
Adani Enterprises 2409.25
Amrapali Industries 17.58
Rashi Peripheral 402.95
Compuage Infocom 3.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.